Get the Stockscreener App
0.00
100.00%
-11.00
Evoke Pharma Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
See More
Previous Close:
$11.00
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$18.95M
Revenue:
$14.42M
Net Income/Loss:
$-5.23M
P/E Ratio:
0.00
EPS:
-2.3826
Net Cash Flow:
$-3.32M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$11.00
Evoke Pharma Inc Stock (EVOK) Company Profile
Name
Evoke Pharma Inc
Sector
Phone
858-345-1494
Address
420 STEVENS AVENUE, SOLANA BEACH, CA
Compare EVOK vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
0.00 | 18.95M | 14.42M | -5.23M | -3.32M | -2.3826 |
TAK
Takeda Pharmaceutical Co Adr
|
17.83 | 56.33B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.67 | 48.83B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
10.07 | 44.83B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.73 | 33.46B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
524.28 | 22.98B | 3.18B | 1.33B | 1.04B | 27.90 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-22-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Mar-05-19 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-08-18 | Reiterated | B. Riley FBR, Inc. | Buy |
| Oct-19-17 | Resumed | FBR & Co. | Buy |
| Mar-16-17 | Reiterated | Rodman & Renshaw | Buy |
| Jan-30-17 | Upgrade | Laidlaw | Neutral → Buy |
| Jan-05-17 | Upgrade | Rodman & Renshaw | Neutral → Buy |
| Dec-23-16 | Reiterated | Rodman & Renshaw | Neutral |
| Jul-19-16 | Reiterated | FBR Capital | Outperform |
| Jul-19-16 | Downgrade | Noble Financial | Buy → Hold |
| Jul-18-16 | Downgrade | Rodman & Renshaw | Buy → Neutral |
| Mar-16-16 | Initiated | Northland Capital | Outperform |
| Mar-14-16 | Reiterated | Ascendiant Capital Markets | Buy |
| Feb-17-16 | Resumed | FBR Capital | Outperform |
| Dec-03-14 | Reiterated | MLV & Co | Buy |
| Nov-07-14 | Initiated | MLV & Co | Buy |
| Apr-22-14 | Initiated | Laidlaw | Buy |
| Nov-19-13 | Initiated | Aegis Capital | Buy |
View All
Evoke Pharma Inc Stock (EVOK) Latest News
If You Invested $1,000 in Biofrontera Inc (BFRI) - Stock Titan
If You Invested $1,000 in Cbdmd Inc (YCBD) - Stock Titan
If You Invested $1,000 in Therapeuticsmd Inc (TXMD) - Stock Titan
If You Invested $1,000 in Evoke Pharma Inc (EVOK) - Stock Titan
Earnings Report: Is Evoke Pharma Inc stock a hidden gemWeekly Trade Analysis & Technical Confirmation Trade Alerts - baoquankhu1.vn
Evoke Pharma Stock Skyrockets On Patent For Nasal Spray That Eases Stomach Delays; Retail Bulls Pile In - MSN
Movement Recap: How does Evoke Pharma Inc compare to its peersMarket Volume Report & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Winners Losers: What technical signals suggest for AAM.U stock2025 Risk Factors & Verified Momentum Stock Alerts - Naître et grandir
Momentum Shift: Will Evoke Pharma Inc benefit from geopolitical trendsEarnings Trend Report & Real-Time Market Sentiment Reports - baoquankhu1.vn
Gastroparesis Market: Rapid Increment Driven by Innovation by 2034DelveInsight - openPR.com
EVOK Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Evoke Pharma Inc. a strong growth stock2025 Trading Recap & AI Forecasted Entry and Exit Points - mfd.ru
Can Evoke Pharma Inc. stock rebound after recent weaknessPortfolio Return Summary & Advanced Technical Analysis Signals - mfd.ru
Why Evoke Pharma Inc. stock could rally in 20252025 Price Action Summary & Daily Stock Trend Watchlist - mfd.ru
BRODSKY & SMITH INVESTOR ALERT: Updates on Investigations for Kenvue Inc. (NYSEKVUE), Sonida Senior Living, Inc. (NYSESNDA), Evoke Pharma Inc. (NasdaqEVOK), and SM Energy Company (NYSESM) - Intellectia AI
Does ProShares Trust ProShares Short 7 10 Year Treasury have declining or rising EPSJuly 2025 Update & Weekly High Momentum Picks - mfd.ru
Is IMOS still a buy after recent gainsPortfolio Gains Report & Weekly Hot Stock Watchlists - mfd.ru
EVOK Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Evoke Pharma’s Volatile Micro?Cap Ride: Can EVOK Break Out Of Its Downtrend? - AD HOC NEWS
Why analysts upgrade Evoke Pharma Inc. stockJuly 2025 PostEarnings & Safe Capital Growth Tips - mfd.ru
How Evoke Pharma Inc. stock performs in interest rate cyclesJuly 2025 Rallies & Verified Entry Point Signals - mfd.ru
Big Money Moves: What is Evoke Pharma Incs 5 year growth outlookJuly 2025 Earnings & Free Community Supported Trade Ideas - baoquankhu1.vn
Can enGene Holdings Inc. Equity Warrant grow without external fundingJuly 2025 Weekly Recap & Verified Trade Idea Suggestions - mfd.ru
Market Recap: Is Artivion Inc stock undervalued right now2025 Technical Patterns & Technical Pattern Alert System - baoquankhu1.vn
Gastroparesis Treatment Market 2026-2033: Growth Overview, - openPR.com
Will Evoke Pharma Inc. stock attract more institutional investors - mfd.ru
Income Plays: What is Evoke Pharma Incs 5 year growth outlook2025 Volatility Report & Verified Short-Term Plans - baoquankhu1.vn
Can Evoke Pharma Inc. continue delivering strong returnsCPI Data & High Conviction Investment Ideas - mfd.ru
How cyclical is Evoke Pharma Inc.’s revenue streamQuarterly Performance Summary & Consistent Return Strategy Ideas - mfd.ru
Institution Moves: Can Evoke Pharma Inc grow without dilutionWeekly Investment Summary & Verified Swing Trading Watchlist - baoquankhu1.vn
Moving Averages: Is Evoke Pharma Inc a speculative investment2025 Valuation Update & Consistent Growth Stock Picks - baoquankhu1.vn
Is Evoke Pharma Inc.’s ROE strong enoughWeekly Trade Summary & Weekly Chart Analysis and Guides - bollywoodhelpline.com
IPO Launch: Is Evoke Pharma Inc stock heavily shortedJuly 2025 Fed Impact & Low Risk Entry Point Guides - baoquankhu1.vn
Evoke Pharma Leads Stock Performance with 149.43% Return Over Past Year - Markets Mojo
Evoke Pharma Achieves 313.53% Return, Leading Recent Stock Performers - Markets Mojo
Is Evoke Pharma Inc. a speculative investmentEarnings Risk Report & Fast Gaining Stock Strategy Reports - bollywoodhelpline.com
Evoke Pharma (NASDAQ:EVOK) Stock Price Passes Above 50 Day Moving Average – Time to Sell? - Defense World
US Market Wrap: What are analysts price targets for Evoke Pharma Inc2025 Fundamental Recap & Low Risk Entry Point Guides - baoquankhu1.vn
AI Stocks: Is Evoke Pharma Inc a speculative investmentJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Wall Street Recap: Will Evoke Pharma Inc benefit from seasonalityJuly 2025 PostEarnings & Low Risk Entry Point Guides - baoquankhu1.vn
Evoke Pharma Leads Micro-Cap Stocks with 137.07% Return Over Past Year - Markets Mojo
Evoke Pharma Leads Micro-Cap Stocks with 149.43% Return Over Past Year - MarketsMojo
Evoke Pharma Achieves 304.41% Return, Leading Micro-Cap Stock Performance - MarketsMojo
Will Evoke Pharma Inc. stock benefit from commodity prices2025 AllTime Highs & Low Risk High Win Rate Picks - Улправда
How The Story Behind Evoke (LSE:EVOK) Is Changing With Takeover Terms And UK Gaming Tax - Yahoo Finance
Evoke Pharma Achieves 313.53% Return Amid Mixed Micro-Cap Performance - Markets Mojo
What technical charts say about Evoke Pharma Inc. stock - ulpravda.ru
Will Evoke Pharma Inc. stock keep outperforming rivalsJuly 2025 Fed Impact & Daily Risk Controlled Trade Plans - Улправда
Will Evoke Pharma Inc. stock gain from strong economyWeekly Profit Analysis & High Accuracy Trade Alerts - ulpravda.ru
Why Evoke Pharma Inc. stock is considered a top pickEarnings Trend Report & Fast Entry High Yield Stock Tips - Улправда
How Evoke Pharma Inc. stock performs in rate cut cyclesWeekly Trade Summary & Capital Efficiency Focused Strategies - Улправда
Evoke Pharma Inc Stock (EVOK) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):